ArticleGenes2022

Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with

Mizuki Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.